Multiplexing technology offers the ability to concurrently evaluate numerous cytokines and biomarkers, providing time-, labor-, and resourcesaving advantages vs. conventional assays that only measure one analyte at a time. Because our core laboratory performs multiplex immunoassays using both the bead-based fluorescence MILLIPLEX® assay with Luminex xMAP® Technology and the Meso Scale Discovery (MSD) planar electrochemiluminescence system, we compared their performance in the 96-well microplate format.
Read Study